Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis
Institute of Human
Nutrition, University of Southampton, Southampton SO16 6YD, UK
Correspondence to: Dr J L Murphy, Clinical Nutrition and Metabolism Unit, Mailpoint 113, Level C West Wing, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK.
Accepted 5 February
1998
AIM
To examine the
gastrointestinal handling and metabolic disposal of emulsified
[1-13C]palmitic acid esterified into a triglyceride in
nine healthy children and seven patients with cystic fibrosis on enzyme
replacement treatment.
METHODS
After an
overnight fast, each child was given 10 mg/kg body weight
[1,1,1-13C]tripalmitin with a standardised test
meal of low natural 13C abundance. The total enrichment of
13C was measured using isotope ratio mass spectrometry in
stool collected for a period of up to five days and in breath samples collected over a 24 hour period.
RESULTS
The mean
proportion of administered 13C label excreted in stool was
6% (range, 1-12.7%) in healthy children and 24.6% (range, 0-64%)
in patients with cystic fibrosis. Healthy children excreted 31.3% of
the administered label on their breath (range, 14.2-42.9%). Correcting the excretion of administered 13C label on the
breath for differences in digestion and absorption in patients with
cystic fibrosis increased the difference between individuals from
0-31.3% of administered dose (mean, 17.9%) to 0-49.1% of absorbed
dose (mean, 23.2%) and was poorly related to the amount of
13C label in stool.
CONCLUSION
Measurements
of breath 13CO2 do not consistently reflect the
gastrointestinal handling of emulsified 13C labelled
tripalmitin because of differences in digestion and absorption in
cystic fibrosis. Further studies need to examine whether "breath
tests" alone can predict with confidence the gastrointestinal handling of other 13C labelled triglycerides and fatty acids.
© 1998 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Trabulsi, J., Schall, J. I, Ittenbach, R. F, Olsen, I. E, Yudkoff, M., Daikhin, Y., Zemel, B. S, Stallings, V. A
(2006). Energy balance and the accuracy of reported energy intake in preadolescent children with cystic fibrosis.. Am. J. Clin. Nutr.
84: 523-530
[Abstract] [Full Text] -
Schuette, S. A., Janghorbani, M., Cohen, M. B., Krug, S., Schindler, T., Wagner, D. A., DiMagno, E. P.
(2003). Effect of Triglyceride Structure on Fecal Excretion of 13C-Labeled Triglycerides. J. Am. Coll. Nutr.
22: 511-518
[Abstract] [Full Text] -
Murphy, J L, Badaloo, A V, Chambers, B, Forrester, T E, Wootton, S A, Jackson, A A
(2002). Maldigestion and malabsorption of dietary lipid during severe childhood malnutrition. Arch. Dis. Child.
87: 522-525
[Abstract] [Full Text] -
Verkade, H. J
(1999). Reply to J Murphy et al. Am. J. Clin. Nutr.
70: 945-946
[Full Text] -
Murphy, J., Laiho, K., Wootton, S.
(1999). Fat malabsorption in cystic fibrosis patients. Am. J. Clin. Nutr.
70: 943-944
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



